Find support groups, events and resources near you

ZERO Summit 2021 banner

Prostate Cancer Treatment Overview: What's Changing

Dennis Stanley in a hospital bed

Join Dr. Alicia Morgans and Dr. Kelvin Moses to enhance your grasp of prostate cancer treatments, including clinical trial insights and upcoming advancements, empowering you and your treatment team to make informed decisions for you and your loved ones.

This session was part of our VIRTUAL ZERO Prostate Cancer Summit, a free online event that took place from February 28 to March 4, 2021.


Watch

Contributors

Woman with long brown hair in a white coat, Dr. Alicia Morgans
Alicia Morgans, MD, MPH, Medical Director, Survivorship Program

Alicia Morgans, MD, MPH is the Chair of ZERO's Medical Advisory Board. Dr. Morgans is a Genitourinary Medical Oncologist and Medical Director of Survivorship Program at Dana-Farber Cancer Institute in Boston, Massachusetts. She specializes in the treatment of genitourinary malignancies, including cancers of the prostate, bladder, testis (germ cell), and penis.

She received a Bachelor’s degree with honors in biology before going to medical school at the University of Pennsylvania School of Medicine. She then went on to complete a residency in internal medicine at the Hospital of the University of Pennsylvania in Philadelphia.

Dr. Morgans completed a fellowship in Hematology/Oncology at Harvard’s Dana Farber Cancer Institute and Massachusetts General Hospital Cancer Center in Boston before becoming an Assistant Professor of Medicine at Vanderbilt University Medical Center. She also has achieved a Masters in Public Health.

Dr. Kelvin Moses
Kelvin Moses, MD, PhD, Associate Professor, Urologic Surgery

Dr. Kelvin A. Moses is an Associate Professor of Urologic Surgery at Vanderbilt University Medical Center, and director of the Comprehensive Prostate Cancer Clinic.

Share